A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization

Fertility and Sterility

Volumn 93, Issue 2, 2010, Pages 360-363

  Berin, Inna ^a   Stein, Daniel E ^a   Keltz, Martin D ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

flare protocol; GnRH agonist; GnRH antagonist; poor responder

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; LEUPRORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 74449093747     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.11.007     Document Type: Article

References (18)

1. Droesch K., Muasher S., Brzyski R., Jones G., Simonetti S., Liu H., and Rosenwaks Z. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 51 (1989) 292-297
2. Serafini P., Stone B., Kerin J., Batzofin J., Quinn P., and Marrs R. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 49 (1988) 90-95
3. Muasher S.J. Controversies in assisted reproduction: treatment of low responders. J Assist Reprod Genet 10 (1993) 112-114
4. Feldberg D., Farhi J., Ashkenazi J., Dicker D., Shalev J., and Ben Rafael Z. Minidose gonadotropin releasing hormone agonist is the treatment choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 62 (1994) 343-346
5. Horvath P., Styler M., Hammond J., Shelden R., and Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 49 (1988) 159-162
6. Confino E., Zhang X., and Kazer R. GnRHa flare and IVF pregnancy rates. Int J Gynaecol Obstet 85 (2004) 36-39
7. Toth T., Awwad J., Veeck L., Jones H., and Muasher S. Suppression and flare regimens of gonadotropin-releasing hormone agonist. J Reprod Med 41 (1996) 321-326
8. Padilla S., Dugan K., Maruschak V., Shalika S., and Smith R. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril 65 (1996) 796-799
9. Fasoulitis S., Laufer N., Sabbagh-Ehrlich S., Lewin A., Hurwitz A., and Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 20 (2003) 455-460
10. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., and Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 16 (2001) 868-870
11. Karande V., Morris R., Rinehart J., Miller C., Rao R., and Gleicher N. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 67 (1997) 900-903
12. Leonidris M., Escalpes M., Segars J., Scott R., and Miller B. Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril 72 (1999) 1018-1023
13. Surrey E., Bower J., Hill D., Ramsey J., and Surrey M. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424
14. Mohamed K., Davies W., Allsopp J., and Lashen H. Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 83 (2005) 331-335
15. Schmidt D., Bremner T., Orris J., Maier D., Benadiva C., and Nulsen J. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 83 (2005) 1568-1571
16. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., and Bahceci M. Addition of GnRH-antagonist in cycles of poor responders undergoing IVF. Hum Reprod 15 (2000) 2145-2147
17. Nikolettos N., Al-Hasani S., Felberbaum R., Demirel L.C., Kupker W., Montzka P., et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 97 (2001) 202-207
18. Olivennes F., Balaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formulation of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320